Literature DB >> 19132115

The fission yeast model for the lysosomal storage disorder Batten disease predicts disease severity caused by mutations in CLN3.

Rebecca L Haines1, Sandra Codlin, Sara E Mole.   

Abstract

The function of the CLN3 protein, which is mutated in patients with the neurodegenerative lysosomal storage disorder Batten disease, has remained elusive since it was identified 13 years ago. Here, we exploited the Schizosaccharomyces pombe model to gain new insights into CLN3 function. We modelled all missense mutations of CLN3 in the orthologous protein Btn1p, as well as a series of targeted mutations, and assessed trafficking and the ability of the mutant proteins to rescue four distinct phenotypes of btn1Delta cells. Mutating the C-terminal cysteine residues of Btn1p caused it to be internalised into the vacuole, providing further evidence that this protein functions from pre-vacuole compartments. Mutations in the lumenal regions of the multi-spanning membrane protein, especially in the third lumenal domain which contains a predicted amphipathic helix, had the most significant impact on Btn1p function, indicating that these domains of CLN3 are functionally important. Only one mutant protein was able to rescue the cell curving phenotype (p.Glu295Lys), and since this mutation is associated with a very protracted disease progression, this phenotype could be used to predict the disease severity of novel mutations in CLN3. The ability to predict disease phenotypes in S. pombe confirms this yeast as an invaluable tool to understanding Batten disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19132115      PMCID: PMC2615160          DOI: 10.1242/dmm.000851

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  38 in total

1.  Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells.

Authors:  Aija Kyttälä; Gudrun Ihrke; Jouni Vesa; Michael J Schell; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

2.  Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).

Authors:  J M Holopainen; J Saarikoski; P K Kinnunen; I Järvelä
Journal:  Eur J Biochem       Date:  2001-11

3.  Membrane topology of CLN3, the protein underlying Batten disease.

Authors:  Qinwen Mao; Brian J Foster; Haibin Xia; Beverly L Davidson
Journal:  FEBS Lett       Date:  2003-04-24       Impact factor: 4.124

4.  Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.

Authors:  P B Munroe; A M O'Rawe; H M Mitchison; I E Järvelä; P Santavuori; T J Lerner; P E Taschner; R M Gardiner; S E Mole
Journal:  Neuropediatrics       Date:  1997-02       Impact factor: 1.947

5.  Molecular genetic analysis of fission yeast Schizosaccharomyces pombe.

Authors:  S Moreno; A Klar; P Nurse
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 6.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

7.  A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.

Authors:  Yoojin Kim; Denia Ramirez-Montealegre; David A Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

8.  Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.

Authors: 
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

9.  A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course.

Authors:  Laura Aberg; Leena Lauronen; Janne Hämäläinen; Sara E Mole; Taina Autti
Journal:  Pediatr Neurol       Date:  2009-02       Impact factor: 3.372

10.  Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein.

Authors:  Junji Ezaki; Mitsue Takeda-Ezaki; Masato Koike; Yoshiyuki Ohsawa; Hikari Taka; Reiko Mineki; Kimie Murayama; Yasuo Uchiyama; Takashi Ueno; Eiki Kominami
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

View more
  4 in total

Review 1.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

2.  Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease.

Authors:  Christopher J Minnis; StJohn Townsend; Julia Petschnigg; Elisa Tinelli; Jürg Bähler; Claire Russell; Sara E Mole
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

3.  Unique Variant Spectrum in a Jordanian Cohort with Inherited Retinal Dystrophies.

Authors:  Bilal Azab; Zain Dardas; Dunia Aburizeg; Muawyah Al-Bdour; Mohammed Abu-Ameerh; Tareq Saleh; Raghda Barham; Ranad Maswadi; Nidaa A Ababneh; Mohammad Alsalem; Hana Zouk; Sami Amr; Abdalla Awidi
Journal:  Genes (Basel)       Date:  2021-04-19       Impact factor: 4.096

Review 4.  Cellular models of Batten disease.

Authors:  Christopher J Minnis; Christopher D Thornton; Lorna M FitzPatrick; Tristan R McKay
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-23       Impact factor: 5.187

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.